IL130074A0 - A whole blood/mitogen assay for the early detection of a subject with cancer and kit - Google Patents

A whole blood/mitogen assay for the early detection of a subject with cancer and kit

Info

Publication number
IL130074A0
IL130074A0 IL13007497A IL13007497A IL130074A0 IL 130074 A0 IL130074 A0 IL 130074A0 IL 13007497 A IL13007497 A IL 13007497A IL 13007497 A IL13007497 A IL 13007497A IL 130074 A0 IL130074 A0 IL 130074A0
Authority
IL
Israel
Prior art keywords
cancer
kit
subject
whole blood
early detection
Prior art date
Application number
IL13007497A
Original Assignee
Shiloov Medical Technologies L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/755,413 external-priority patent/US6322989B1/en
Priority claimed from US08/755,287 external-priority patent/US20020006608A1/en
Application filed by Shiloov Medical Technologies L filed Critical Shiloov Medical Technologies L
Publication of IL130074A0 publication Critical patent/IL130074A0/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL13007497A 1996-11-22 1997-11-21 A whole blood/mitogen assay for the early detection of a subject with cancer and kit IL130074A0 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US75524096A 1996-11-22 1996-11-22
US75523296A 1996-11-22 1996-11-22
US75541296A 1996-11-22 1996-11-22
US75541596A 1996-11-22 1996-11-22
US75541496A 1996-11-22 1996-11-22
US08/755,413 US6322989B1 (en) 1991-11-25 1996-11-22 Whole blood/mitogen assay for the early detection of a subject with ovarian or breast cancer and kit
US08/755,287 US20020006608A1 (en) 1991-11-25 1996-11-22 Whole blood/mitogen assay for the early detection of a subject infected with hepatitis c virus and kit
PCT/IL1997/000381 WO1998022825A2 (en) 1996-11-22 1997-11-21 A whole blood/mitogen assay for the early detection of a subject with cancer and kit

Publications (1)

Publication Number Publication Date
IL130074A0 true IL130074A0 (en) 2000-02-29

Family

ID=27569910

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13007497A IL130074A0 (en) 1996-11-22 1997-11-21 A whole blood/mitogen assay for the early detection of a subject with cancer and kit

Country Status (6)

Country Link
EP (1) EP0943095A2 (en)
JP (1) JP2001504233A (en)
AU (1) AU5066098A (en)
CA (1) CA2272924A1 (en)
IL (1) IL130074A0 (en)
WO (1) WO1998022825A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19681033D2 (en) 1995-11-16 1999-03-18 Michael W Dahm Method for the quantification of tumor cells in a body fluid and suitable test kits
DE19804372A1 (en) 1998-02-04 1999-08-05 Michael W Dr Dr Dahm Method for the quantitative determination of tumor cells in a body fluid and suitable test kits
CA2580795A1 (en) * 2004-09-22 2006-04-06 Tripath Imaging, Inc. Methods and compositions for evaluating breast cancer prognosis
EP1802776B1 (en) * 2004-10-20 2013-01-02 Hitachi Chemical Company, Ltd. Method for tailoring administration of drugs by quantitation of mrna
JP2011502535A (en) 2007-11-14 2011-01-27 日立化成工業株式会社 Tumor necrosis factor superfamily mRNA expression through Fc receptors in peripheral blood leukocytes
US11028443B2 (en) 2015-08-31 2021-06-08 Showa Denko Materials Co., Ltd. Molecular methods for assessing urothelial disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0203403B1 (en) * 1985-05-01 1992-10-28 Asahi Kasei Kogyo Kabushiki Kaisha A cloned t cell capable of recognizing tumors and a t cell antigen receptor
CA1305912C (en) * 1987-06-22 1992-08-04 Richard J. Albertini Detection of lymphocyte amplification
WO1993011435A1 (en) * 1991-11-25 1993-06-10 Cohen Steven J Method and kit for the detection of antibodies in seronegative individuals
EP0624189A4 (en) * 1992-01-21 1995-05-17 Ludwig Inst Cancer Res Method for determining cytolytic t cell precursors.
CA2134460A1 (en) * 1992-04-30 1993-11-11 Kazuhiko Yamamoto Method for detecting expression of t cell receptor genes
DE19515219A1 (en) * 1995-04-28 1996-10-31 Gabriele Dr Pecher Assay for tumour-specific cytotoxic T cells

Also Published As

Publication number Publication date
WO1998022825A2 (en) 1998-05-28
CA2272924A1 (en) 1998-05-28
AU5066098A (en) 1998-06-10
EP0943095A2 (en) 1999-09-22
JP2001504233A (en) 2001-03-27
WO1998022825A3 (en) 1998-08-06

Similar Documents

Publication Publication Date Title
EP0944642A4 (en) Dioxetane labeled probes and detection assays employing the same
AU4269589A (en) Assay and sensing means for determining analyte
AU640162B2 (en) Blood separation and analyte detection techniques
BR9707132A (en) Fastener set with peripheral seal
AU629616B2 (en) Slide fastener and fastener elements therefor
HK1033773A1 (en) An assay for detecting anti-hepatitis c virus and the kit therefor.
EP0677734A3 (en) Detection of a target substance in a sample.
IL126534A (en) Methods of diagnosing clinical subtypes of crohn's disease and a kit for diagnosing the same
GB9727296D0 (en) Assay and kit for determining the condition of cells
IL108879A (en) Diagnostic assay for malignancies using the H19 gene and kit
EP0473065A3 (en) Simultaneous assay for detecting two or more analytes
EP0882230A4 (en) Chemiluminescent assay methods and devices for detecting target analytes
AU4528696A (en) Cancer detection probes
IL130074A0 (en) A whole blood/mitogen assay for the early detection of a subject with cancer and kit
AU2191297A (en) Blood testing kit
IL88831A0 (en) Blood assay
GB9406210D0 (en) Detection of analytes
AU7713498A (en) Immunoassay for the detection of cancer
IL91414A0 (en) Reagents and methods for the determination of analytes
GB9420641D0 (en) Blood sample analysis
AU1288499A (en) Methods of identifying and diagnosing inflammatory bowel disease or subtypes with the nramp locus
GB9406209D0 (en) Detection of analytes
AU6727598A (en) In vitro determination for detection of tumors of the intestine
AU2607495A (en) Heterogeneous immunoassay and the use thereof for detecting proteins
ZA956671B (en) Detection of high risk factor to develop cataract and a reagent kit for the detection